(Q81251714)

English

Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research

scientific article published on 01 July 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

B-cell non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

Ewa Kalinka-Warzocha

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Bernadeta Ceglarek

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Krzysztof Warzocha

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Ewa Lech-Marańda

3

object named as

Ewa Lech-Maranda

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jerzy Hołowiecki

5

object named as

Jerzy Holowiecki

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

9

object named as

Tadeusz Robak

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Jarosław Czyż

8

object named as

Jaroslaw Czyz

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Polish Lymphoma Research Group

11

object named as

Polish Lymphoma Research Group

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Irena Federowicz

6

object named as

Irena Federowicz

1 reference

Europe PubMed Central

PubMed publication ID

7 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

author name string

Jaroslaw Wajs

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

113

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

367-375

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III Intergroup Study of Fludarabine Phosphate Compared With Cyclophosphamide, Vincristine, and Prednisone Chemotherapy in Newly Diagnosed Patients With Stage III and IV Low-Grade Malignant Non-Hodgkin's Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab combined with cladribine or with cladribine and cyclophosphamide in heavily pretreated patients with indolent lymphoproliferative disorders and mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Infections associated with purine analogs and monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Fludarabine containing-regimens may adversely affect peripheral blood stem cell collection in low-grade non Hodgkin lymphoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23558

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23558

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18470902%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81251714&oldid=2118788759"